elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48327816-471E0F54-5E90-4065-8154-C9C6CD00A4E9
Q48327816-471E0F54-5E90-4065-8154-C9C6CD00A4E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48327816-471E0F54-5E90-4065-8154-C9C6CD00A4E9
Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.
P1476
Q48327816-471E0F54-5E90-4065-8154-C9C6CD00A4E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48327816-471E0F54-5E90-4065-8154-C9C6CD00A4E9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a535cfea6aed71656de80708b8bb26bcff3702ab
P1476
Early drug and anti-infliximab
......
esponse to infliximab therapy.
@en